Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

36,950

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,732

Class I recallsReasonable probability of serious health consequences

24,263

Class II recallsTemporary or medically reversible health consequences

2,873

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,071 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/made-fresh-salads-inc-recalls-ready-eat-deli-style-salads-and-cream-cheese-because-possible-healthPublished September 6, 2026

Most affected stateHawaii 200 recalls mention this state

State: ND ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 7, 2026 ET

Summary (Year to date)

1,458 recalls have been announced year to date.
Aug 2026 was 53% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,263
Class I	9,732
Class III	2,873
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,263
Class I	9,732
Class III	2,873
Not Yet Classified	1

FDA Recall Ongoing Historical recordClass II

Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05

by USV Private Limited

Reason: Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
Published: October 29, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50

by JB Chemicals and Pharmaceuticals Ltd

Reason: Tablet/Capsules Imprinted with Wrong ID
Published: October 29, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10.

by JB Chemicals and Pharmaceuticals Ltd

Reason: Tablet/Capsules Imprinted with Wrong ID
Published: October 29, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61 (Blister pack), NDC 55154-3363-0 (Outer Bag).

by The Harvard Drug Group LLC

Reason: Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
Published: October 29, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61

by The Harvard Drug Group LLC

Reason: Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
Published: October 29, 2025
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

M.C.I. Foods, Inc.

Product: Egg and Cheese Breakfast Burrito; 3.75 oz; 72 count/case; U…
Reason: Cooked egg ingredient for Ready-to-Eat products tested positive for Listeria Monocytogenes
Published: October 29, 2025
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

M.C.I. Foods, Inc.

Product: Cheese and Egg with Green Salsa Breakfast Burrito; 3.75 oz;…
Reason: Cooked egg ingredient for Ready-to-Eat products tested positive for Listeria Monocytogenes
Published: October 29, 2025
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

DEMERS FOOD GROUP LLC

Product: Scott & Jon s Shrimp Scampi with Linguine, 9.6 oz.
Reason: Contains Linguine manufactured by Nate's Fine Foods LLC recalled for Listeria monocytogenes and implicated in ongoing outbreak
Published: October 29, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01

by Rising Pharma Holding, Inc.

Reason: Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30

by ASTRAZENECA PHARMACEUTICALS

Reason: Lack of Assurance of Sterility:
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

by Amerisource Health Services LLC

Reason: CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91

by ENDO USA, Inc.

Reason: Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.

by STAQ Pharma, Inc.

Reason: Labeling: Incorrect or Missing Lot and/or Exp Date
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.

by STAQ Pharma, Inc.

Reason: Labeling: Incorrect or Missing Lot and/or Exp Date
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

by STAQ Pharma, Inc.

Reason: Labeling: Incorrect or Missing Lot and/or Exp Date
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Aloe Up Sport Performance Sunscreen Lotion SPF 30, 1 FL OZ (30 mL) per tube, Mfd. for: ALOE UP, 9700 W. 76th St., Ste 112, Eden Prairie, Minnesota 55344

by SV Labs Prescott Corporation

Reason: cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 Blisters each containing 28 Tablets, Rx only, 28 day Regimen, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA., Mahwah, NJ, 07430, NDC 68462-318-29.

by Glenmark Pharmaceuticals Inc., USA

Reason: Failed Impurities/Degradation Specifications
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDC 67877-514-05), Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054

by Ascend Laboratories, LLC

Reason: Failed Dissolution Specifications
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDC 67877-512-05), c). 1000-count(NDC 67877-512-10),Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.

by Ascend Laboratories, LLC

Reason: Failed Dissolution Specifications
Published: October 22, 2025
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count (NDC 67877-513-05), c). 1000-count (NDC 67877-513-10), Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.

by Ascend Laboratories, LLC

Reason: Failed Dissolution Specifications
Published: October 22, 2025
Distribution: Nationwide

View recall →

Data last updated: September 7, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.